Navigation Links
Volcano Announces Closing of CardioSpectra Acquisition
Date:12/18/2007

SAN DIEGO, Dec. 18 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a provider of intravascular ultrasound (IVUS) and functional measurement (FM) products designed to enhance the diagnosis and treatment of vascular and structural heart disease, announced today that it has completed its previously announced acquisition of CardioSpectra, Inc.

CardioSpectra is a privately-held company developing innovative Optical Coherence Tomography (OCT) technology. CardioSpectra's unique OCT imaging system is expected to complement Volcano's existing product offerings and further enhance Volcano's position as an imaging technology leader in the field of interventional medicine.

Under terms of the agreement, which was announced on December 10, 2007, Volcano paid $25 million in cash at closing to CardioSpectra's shareholders and warrant holders. In addition, Volcano may make additional payments upon the achievement of certain product development, regulatory and revenue milestones. Any future payment may be made in cash or stock, or a combination of both at Volcano's discretion.

About Volcano

Volcano Corporation (Nasdaq: VOLC) offers a broad suite of devices designed to facilitate endovascular procedures, enhance the diagnosis of vascular and structural heart disease and guide optimal therapies. The company's intravascular ultrasound (IVUS) product line includes ultrasound consoles that can be integrated directly into virtually any modern cath lab. Volcano IVUS offers unique features, including b
'/>"/>

SOURCE Volcano Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Volcano Corporation Presentation at Bear Stearns Conference to be Webcast
2. Volcano Corporation Announces Pricing of Common Stock Offering
3. Volcano Announces Activities at TCT 2007: Expanded Role of IVUS in PCI to be Demonstrated
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
6. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
7. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
8. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
9. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... , February 26, 2015 ... subjects into PEACH, the first pivotal trial of ... dependent chronic kidney disease (DD-CKD), has completed as ... PT20, invented by leading UK-based scientists ... by Phosphate Therapeutics, is a novel phosphate binder ...
(Date:2/25/2015)... -- Today, BioMed Realty Trust, Inc. (NYSE: ... promotions and additions to its leadership team focused on ... returns through strategic investments in real estate at the ... innovation sector. The company also announced ... his role as President and Chief Operating Officer to ...
(Date:2/25/2015)... February 25, 2015 Salt ... $604,000 grant from the National Science Foundation’s ... (STEM) program. , The Foundation’s program supports scholarships ... enabling them to enter the workforce following completion ... STEM discipline. Institutions throughout the U.S. annually vie ...
(Date:2/25/2015)... February 25, 2015 FloDesign Sonics, Inc. ... Board of Directors. Michael “Mike” J. Harsh served as ... till Dec 2014, and led their Global Science and ... board will have a profound impact on our company. ... development of acoustic based products in life sciences. He ...
Breaking Biology Technology:Phosphate Therapeutics Announces Completion of Subject Recruitment Into the PEACH Pivotal Phase 2 Study of its Novel Phosphate Binder (PT20) for the Treatment of Hyperphosphataemia 2Phosphate Therapeutics Announces Completion of Subject Recruitment Into the PEACH Pivotal Phase 2 Study of its Novel Phosphate Binder (PT20) for the Treatment of Hyperphosphataemia 3BioMed Realty Announces Realignment To Leverage Depth Of Life Science Real Estate Expertise And Increase Shareholder Value 2BioMed Realty Announces Realignment To Leverage Depth Of Life Science Real Estate Expertise And Increase Shareholder Value 3BioMed Realty Announces Realignment To Leverage Depth Of Life Science Real Estate Expertise And Increase Shareholder Value 4SLCC Receives $600K National Science Foundation Grant 2FloDesign Sonics Inc adds Michael Harsh, Prior CTO GE Healthcare, to Board of Directors 2FloDesign Sonics Inc adds Michael Harsh, Prior CTO GE Healthcare, to Board of Directors 3
... Menards has selected a series of technology ... the company said Wednesday. , ,Menards deployed a ... Teradata Retail Logical Date Model. , ,Menards previously ... provide the information business users were demanding and often ...
... - The life sciences provider Promega broke ground on ... the Fitchburg Center, located next to the existing Promega offices. ... feet located near Cheryl Parkway and Fish Hatchery Road, 62,000 ... which will be retail space. The expansion will provide Promega ...
... Wis. -- The Medical College of Wisconsin has ... mechanisms by which inhaled anesthetics protect the human heart ... occurring during heart surgery. The college also has received ... injuries. , ,Zeljko Bosnjak, Ph.D., professor and vice chairman ...
Cached Biology Technology:
(Date:2/11/2015)... According to a ... Product (Cards and Readers, Biometrics, Controllers, Management Software), ... Healthcare, Education) and By Geography - Global Forecast and Analysis to ... Control Market is expected to reach $10.4 ... of 10.6% between 2014 and 2020. ...
(Date:2/5/2015)... , 5. Februar 2015 ... spezialisiertes Logistikunternehmen und hat eine neue Marketingkampagne ... Logistikfirma (Clinical Logistics Organization – CLO) der ... Kampagne lautet First , mit Schwerpunkt ... Foto: http://photos.prnewswire.com/prnh/20150205/173753 Logo ...
(Date:2/5/2015)... Jan. 26, 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile commerce ... ( http://www.nxt-id.com/ ) as part of its 2015 marketing ... Company launched its new consumer website for Wocketwallet.com earlier ... CEO of NXT-ID said, "Our new corporate website naturally ...
Breaking Biology News(10 mins):Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Marken startet Kampagne mit Patienten im Mittelpunkt 2Marken startet Kampagne mit Patienten im Mittelpunkt 3NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3
... this webpage for pictures and videos! , ... as sea lilies look a lot like their garden-variety namesakes. ... sea lilies stayed rooted instead of moving around like their ... from a submersible research vessel at a depth of 430 ...
... to the Earth's landscape , The ice ages made massive ... the ice in the oceans? , Research by marine scientists ... whole communities of animals were wiped out by ice sheets ... been thought that these ecosystems somehow dodged extinction by recolonising ...
... The ice ages made massive changes to the Earth's landscape ... landscape. But what was happening below the ice in the ... a time of mass destruction as whole communities of animals ... , In the past it has been thought that these ...
Cached Biology News:Creeping crinoids! Sea lilies crawl to escape predators, new video shows 2Creeping crinoids! Sea lilies crawl to escape predators, new video shows 3Gene therapy may protect normal tissues during radiation retreatment for lung cancer 2Seafloor creatures destroyed by ice action during ice ages 2
Anti-LC3 Polyclonal Antibody Research Focus: cell surface antigens Storage: -20C Shipping Temperature: +4C...
Mouse monoclonal [SPM325] to Xanthine Oxidase, prediluted ( Abpromise for all tested applications). Antigen: C terminal 358 amino acid fragment of human xanthine oxidase. Entrez Gene ID: 749...
Rabbit polyclonal to Xanthine Oxidase (HRP) ( Abpromise for all tested applications). Antigen: Xanthine Oxidase (from Bovine Buttermilk) Entrez Gene ID: 7498 Swiss Protein ID: P47989...
... Disrupts biological cells for DNA isolation. ... well plates (includes 96 well plate ... lysis across the entire plate length ... Can be used for soil, ...
Biology Products: